These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25050906)

  • 21. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
    Niikura M; Bance N; Mohan S; Mario Pinto B
    Antiviral Res; 2011 Jun; 90(3):160-3. PubMed ID: 21443905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro.
    Pietrantoni A; Dofrelli E; Tinari A; Ammendolia MG; Puzelli S; Fabiani C; Donatelli I; Superti F
    Biometals; 2010 Jun; 23(3):465-75. PubMed ID: 20232110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV.
    Hayashi K; Kamiya M; Hayashi T
    Planta Med; 1995 Jun; 61(3):237-41. PubMed ID: 7617766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
    Yeh JY; Coumar MS; Horng JT; Shiao HY; Kuo FM; Lee HL; Chen IC; Chang CW; Tang WF; Tseng SN; Chen CJ; Shih SR; Hsu JT; Liao CC; Chao YS; Hsieh HP
    J Med Chem; 2010 Feb; 53(4):1519-33. PubMed ID: 20092255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus.
    Liu G; Xiong S; Xiang YF; Guo CW; Ge F; Yang CR; Zhang YJ; Wang YF; Kitazato K
    Arch Virol; 2011 Aug; 156(8):1359-69. PubMed ID: 21479599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
    An L; Liu R; Tang W; Wu JG; Chen X
    Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides.
    Kwok T; Helfer H; Alam MI; Heinrich J; Pavlovic J; Moelling K
    Arch Virol; 2009; 154(1):109-14. PubMed ID: 19034603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza virus overcomes apoptosis by rapid multiplication.
    Kurokawa M; Koyama AH; Yasuoka S; Adachi A
    Int J Mol Med; 1999 May; 3(5):527-30. PubMed ID: 10202186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro antiviral activity of antisense oligonucleotides against influenza virus].
    Chen Z; Wang S; Guan W; Yang B; Sun Z
    Wei Sheng Wu Xue Bao; 2000 Oct; 40(5):482-7. PubMed ID: 12548758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protein kinase inhibitor flavopiridol inhibits the replication of influenza virus in vitro].
    Wang S; Zhang J; Ye X
    Wei Sheng Wu Xue Bao; 2012 Sep; 52(9):1137-42. PubMed ID: 23236848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral effect of strictinin on influenza virus replication.
    Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
    Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.
    Yamada H; Moriishi E; Haredy AM; Takenaka N; Mori Y; Yamanishi K; Okamoto S
    Antiviral Res; 2012 Dec; 96(3):344-52. PubMed ID: 23022352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
    Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
    Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral effects of atropine and caffeine.
    Yamazaki Z; Tagaya I
    J Gen Virol; 1980 Oct; 50(2):429-31. PubMed ID: 6257827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of influenza-virus-induced apoptosis in chorion cells of human fetal membranes by nordihydroguaiaretic Acid.
    Uchide N; Ohyama K; Bessho T; Toyoda H
    Intervirology; 2005; 48(5):336-40. PubMed ID: 15956802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors.
    Xie Y; Huang B; Yu K; Xu W
    Bioorg Med Chem; 2013 Dec; 21(24):7715-23. PubMed ID: 24262883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses.
    Langland J; Jacobs B; Wagner CE; Ruiz G; Cahill TM
    Antiviral Res; 2018 Dec; 160():143-150. PubMed ID: 30393014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.